» Articles » PMID: 33590946

Hallmarks of the Aging T-cell System

Overview
Journal FEBS J
Specialty Biochemistry
Date 2021 Feb 16
PMID 33590946
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

The adaptive immune system has the enormous challenge to protect the host through the generation and differentiation of pathogen-specific short-lived effector T cells while in parallel developing long-lived memory cells to control future encounters with the same pathogen. A complex regulatory network is needed to preserve a population of naïve cells over lifetime that exhibit sufficient diversity of antigen receptors to respond to new antigens, while also sustaining immune memory. In parallel, cells need to maintain their proliferative potential and the plasticity to differentiate into different functional lineages. Initial signs of waning immune competence emerge after 50 years of age, with increasing clinical relevance in the 7th-10th decade of life. Morbidity and mortality from infections increase, as drastically exemplified by the current COVID-19 pandemic. Many vaccines, such as for the influenza virus, are poorly effective to generate protective immunity in older individuals. Age-associated changes occur at the level of the T-cell population as well as the functionality of its cellular constituents. The system highly relies on the self-renewal of naïve and memory T cells, which is robust but eventually fails. Genetic and epigenetic modifications contribute to functional differences in responsiveness and differentiation potential. To some extent, these changes arise from defective maintenance; to some, they represent successful, but not universally beneficial adaptations to the aging host. Interventions that can compensate for the age-related defects and improve immune responses in older adults are increasingly within reach.

Citing Articles

Epigenetic factors and inflammaging: FOXO3A as a potential biomarker of sarcopenia and upregulation of DNMT3A and SIRT3 in older adults.

Bogucka D, Wajda A, Stypinska B, Radkowski M, Targowski T, Modzelewska E Front Immunol. 2025; 16:1467308.

PMID: 40034697 PMC: 11872893. DOI: 10.3389/fimmu.2025.1467308.


Systematic review and quantitative meta-analysis of age-dependent human T-lymphocyte homeostasis.

Kulesh V, Peskov K, Helmlinger G, Bocharov G Front Immunol. 2025; 16:1475871.

PMID: 39931065 PMC: 11808020. DOI: 10.3389/fimmu.2025.1475871.


A regularized Bayesian Dirichlet-multinomial regression model for integrating single-cell-level omics and patient-level clinical study data.

Guo Y, Yu L, Guo L, Xu L, Li Q Biometrics. 2025; 81(1).

PMID: 39887052 PMC: 11783250. DOI: 10.1093/biomtc/ujaf005.


Booster COVID-19 mRNA vaccination ameliorates impaired B-cell but not T-cell responses in older adults.

Kometani K, Yorimitsu T, Jo N, Yamaguchi E, Kikuchi O, Fukahori M Front Immunol. 2024; 15:1455334.

PMID: 39717779 PMC: 11663736. DOI: 10.3389/fimmu.2024.1455334.


Impact of immunological aging on T cell-mediated therapies in older adults with multiple myeloma and lymphoma.

Ullrich F, Brockelmann P, Turki A, Khan A, Chiru E, Vetter M J Immunother Cancer. 2024; 12(12.

PMID: 39622581 PMC: 11624774. DOI: 10.1136/jitc-2024-009462.


References
1.
Cuddapah S, Barski A, Zhao K . Epigenomics of T cell activation, differentiation, and memory. Curr Opin Immunol. 2010; 22(3):341-7. PMC: 2892201. DOI: 10.1016/j.coi.2010.02.007. View

2.
Gustafson C, Jadhav R, Cao W, Qi Q, Pegram M, Tian L . Immune cell repertoires in breast cancer patients after adjuvant chemotherapy. JCI Insight. 2020; 5(4). PMC: 7101137. DOI: 10.1172/jci.insight.134569. View

3.
Seddon B, Yates A . The natural history of naive T cells from birth to maturity. Immunol Rev. 2018; 285(1):218-232. DOI: 10.1111/imr.12694. View

4.
Shrivastav M, De Haro L, Nickoloff J . Regulation of DNA double-strand break repair pathway choice. Cell Res. 2007; 18(1):134-47. DOI: 10.1038/cr.2007.111. View

5.
Li G, Yu M, Lee W, Tsang M, Krishnan E, Weyand C . Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity. Nat Med. 2012; 18(10):1518-24. PMC: 3466346. DOI: 10.1038/nm.2963. View